Developing a computer algorithm to identify epilepsy cases in managed care organizations

Disease Management

Volumn 8, Issue 1, 2005, Pages 1-14

  Holden, E Wayne ^a   Grossman, Elizabeth ^a   Hoang, Thanh Nguyen ^a   Gunter, Margaret J ^b   Grebosky, Becky ^b   Von Worley, Ann ^b   Nelson, Leila ^b   Robinson, Scott ^b   Thurman, David J ^c  

^a MACRO INTERNATIONAL INC   (United States)

^b LOVELACE CLINIC FOUNDATION   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; AGE; AGED; ALGORITHM; ARTICLE; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; ELECTRONIC MEDICAL RECORD; EPILEPSY; ETHNOLOGY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MENTAL DISEASE; NEUROLOGIC DISEASE; PROBABILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; EPILEPSY; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MEDICAL RECORDS; MIDDLE AGED; NEW MEXICO; RETROSPECTIVE STUDIES;

EID: 14644440783     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2005.8.1     Document Type: Article

References (14)

1. Hauser WA. Recent developments in the epidemiology of epilepsy. Acta Neurol Scand 1995;162:17-21.
2. Sander JW, Hart YM, Johnson AL, et al. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336:1267-1271.
3. Shorvon SD. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia 1996;37:S1-S3.
4. Jallon P. Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology. Epileptic Disord 2002;4:1-13.
5. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-1973.
6. Kotsopoulos IA, van Merode T, Kessels FG, et al. A systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002;43:1402-1409.
7. Annegers JF, Dubinsky S, Coan SP, et al. The incidence of epilepsy and unprovoked seizures in multiethnic, urban health maintenance organizations. Epilepsia 1999;40:502-506.
8. Epstein RS, Sherwood LM. From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 1996;124:832-837.
9. DuChane J, Grebosky B, Gunter M, et al. Electronic case identification for managed care outcomes studies: assessing the reliability of pharmaceutical claims data, diagnosis codes and procedures codes. Presented at the Second Annual International Meeting of the Association for Pharmacoeconomics and Outcomes Research, Philadelphia, 1997.
10. Trost LF. Epilepsy in a managed care organization. Neurology 2000;55:S38-S41.
11. Bell GS, Sander JW. The epidemiology of epilepsy: the size of the problem. Seizure 2001;10:306-316.
12. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105.
13. Gunmit RJ. Seizures and the public's health. Presented at Living Well with Epilepsy II Conference, Baltimore, 2003.
14. Gunter MJ, Brixner D, Von Worley A, et al. Impact of a seizure disorder disease management program on patient-reported quality of life. Dis Manage 2004;7:333-347.